To identify which NSCLCs would be sensitive to SAH-JGZ4 treatment, three more NSCLC cell lines with different expression level of TRIB3 and EGFR (shown in Fig.1a) were tested using in vivo models. Here, EGFR is linked to non-small cell lung carcinoma.